Screener
ClearPoint Neuro CLPT Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | March 31, 2026 / (Unaudited) | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $35,593 | $45,923 |
| Accounts receivable, net | 8,662 | 6,549 |
| Inventory, net | 8,573 | 8,359 |
| Prepaid expenses and other current assets | 2,049 | 2,769 |
| Total current assets | 54,877 | 63,600 |
| Property and equipment, net | 2,914 | 2,621 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's accounts receivable?
- ClearPoint Neuro (CLPT) reported accounts receivable of $8.66M in Q1 2026.
- How has ClearPoint Neuro's accounts receivable changed year-over-year?
- ClearPoint Neuro's accounts receivable increased by 137.3% year-over-year, from $3.65M to $8.66M.
- What is the long-term trend for ClearPoint Neuro's accounts receivable?
- Over 5 years (2020 to 2025), ClearPoint Neuro's accounts receivable has grown at a 28.3% compound annual growth rate (CAGR), from $1.88M to $6.55M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about ClearPoint Neuro's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude